DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acular (Ketorolac Tromethamine Ophthalmic) - News

 
 



News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for

Macular Degeneration
Source: MedicineNet Anemia Specialty [2015.05.07]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/7/2015 12:00:00 AM

Patients with AIDS at increased risk of developing age-related macular degeneration
Source: Eye Health / Blindness News From Medical News Today [2015.05.06]
New study results add to growing body of research that HIV-infected patients may experience age-related diseases earlier in lifePatients with acquired immunodeficiency syndrome (AIDS) have a...

Calcium Supplements Tied to Macular Degeneration
Source: MedicineNet Vitamins and Calcium Supplements Specialty [2015.04.13]
Title: Calcium Supplements Tied to Macular Degeneration
Category: Health News
Created: 4/11/2015 12:00:00 AM
Last Editorial Review: 4/13/2015 12:00:00 AM

Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.

'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010

Regorafenib Eye Drops Show Promise in Primate AMD Model
Source: Medscape Ophthalmology Headlines [2015.05.15]
Regorafenib eye drops may become a 'valuable extension' to current treatment options for wet age-related macular degeneration. However, the project is in an early development phase.
Medscape Medical News

Managing DME in the Anti-VEGF and Corticosteroid Era
Source: Medscape Ophthalmology Headlines [2015.05.11]
Find out more about the important role anti-VEGF agents and corticosteroids have played in the management of diabetic macular edema -- and what challenges remain.
Current Opinion in Ophthalmology

Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015